Who
Lauren White
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Seaport Therapeutics; SVP, CFO and Pfo, ImmunoGen; Chief Financial Officer, C4 Therapeutics.
In numbers
- Trades disclosed
- 26
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 21 Jun 2021
- Last trade
- 4 May 2026
- Last filed
- 4 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 May 2026filed 4 May 2026 | SPTX Seaport TherapeuticsBiotechnology | SEC FORM 4 Code C | —6,702 | filing |
| 4 May 2026filed 4 May 2026 | SPTX Seaport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —21,052 at $0.00 | filing |
| 4 May 2026filed 4 May 2026 | SPTX Seaport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —21,052 at $0.00 | filing |
| 4 May 2026filed 4 May 2026 | SPTX Seaport TherapeuticsBiotechnology | SEC FORM 4 Code C | —6,702 | filing |
| 30 Apr 2026filed 4 May 2026 | SPTX Seaport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —63,680 at $0.00 | filing |
| 30 Apr 2026filed 4 May 2026 | SPTX Seaport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —63,680 at $0.00 | filing |
| 12 Feb 2024filed 12 Feb 2024 | ImmunoGenoption or derivative | SEC FORM 4 Code D | —295,975 | filing |
| 12 Feb 2024filed 12 Feb 2024 | ImmunoGenoption or derivative | SEC FORM 4 Code D | —51,625 | filing |
| 12 Feb 2024filed 12 Feb 2024 | ImmunoGenoption or derivative | SEC FORM 4 Code D | —19,519 | filing |
| 1 Feb 2024filed 5 Feb 2024 | ImmunoGenoption or derivative | SEC FORM 4 Code A | —19,519 at $0.00 | filing |
| 18 Sep 2023filed 19 Sep 2023 | ImmunoGenoption or derivative | SEC FORM 4 Code A | —295,975 at $0.00 | filing |
| 18 Sep 2023filed 19 Sep 2023 | ImmunoGenoption or derivative | SEC FORM 4 Code A | —51,625 at $0.00 | filing |
| 30 Aug 2023filed 31 Aug 2023 | CCCC C4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,250 at $0.00 | filing |
| 30 Aug 2023filed 31 Aug 2023 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code M | —2,250 | filing |
| 30 Aug 2023filed 31 Aug 2023 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code F | $1,937661 at $2.93 | filing |
| 13 Feb 2023filed 15 Feb 2023 | CCCC C4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 13 Feb 2023filed 15 Feb 2023 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 30 Jan 2023filed 1 Feb 2023 | CCCC C4 Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 30 Jan 2023filed 1 Feb 2023 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code M | —3,750 | filing |
| 30 Jan 2023filed 1 Feb 2023 | CCCC C4 TherapeuticsBiotechnology | SEC FORM 4 Code F | $10K1,301 at $7.78 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.